Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sagar Dhoble"'
Autor:
Mostafa F. Abushahba, Alexis S. Dadelahi, Emily L. Lemoine, Jerod A. Skyberg, Swati Vyas, Sagar Dhoble, Vinod Ghodake, Vandana B. Patravale, Jeffrey J. Adamovicz
Publikováno v:
Vaccines, Vol 11, Iss 3, p 546 (2023)
Brucellosis is a zoonotic disease that causes significant negative impacts on the animal industry and affects over half a million people worldwide every year. The limited safety and efficacy of current animal brucellosis vaccines, combined with the l
Externí odkaz:
https://doaj.org/article/d14ab66e51754e7d837e2edf982b218e
Publikováno v:
International Journal of Pharmaceutics: X, Vol 2, Iss , Pp 100053- (2020)
Vaccines delivered via the mucosal route have logistic benefits over parenteral or intramuscular vaccines as they offer patient compliance. This study presents the first intranasal, controlled release, subunit nanovaccine comprising mucoadhesive tama
Externí odkaz:
https://doaj.org/article/a60cbeed687e48dd874d4c78b9eaec8e
Publikováno v:
Drug Delivery and Translational Research. 11:1520-1531
Inhalation route of drug delivery is the most favorable for pulmonary infections wherein direct drug delivery is desired to the lungs. Tuberculosis is one such infection suffering from poor therapeutic efficacy because of low patient compliance due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::930a8eeee9cb1b875843261153ad78a6
https://doi.org/10.1007/s13346-021-01005-5
https://doi.org/10.1007/s13346-021-01005-5
Publikováno v:
Journal of Drug Delivery Science and Technology. 82:104359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de2659336f50b91193ac4982746dbd38
https://doi.org/10.1016/j.jddst.2023.104359
https://doi.org/10.1016/j.jddst.2023.104359
Autor:
Sagar Dhoble, Vandana Patravale
Publikováno v:
AAPS PharmSciTech. 23(5)
Pulmonary hypertension (PH) is characterized by the rise in mean pulmonary arterial pressure (≥ 20 mmHg at rest) due to the narrowing of the pulmonary arterial networks. Current treatments provide symptomatic treatment and the underlying progress o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0295295beff514c45dc455d3daacadaa
https://pubmed.ncbi.nlm.nih.gov/35672540
https://pubmed.ncbi.nlm.nih.gov/35672540
Publikováno v:
Dhoble, S, Patravale, V, Weaver, E, Lamprou, D & Patravale, T 2022, ' Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial hypertension ', International Journal of Pharmaceutics .
Pulmonary Arterial Hypertension (PAH) is the progressive increase in mean pulmonary arterial pressure (mPAP) (≥ 20 mmHg at rest). Current treatment strategies include the drugs targeting at nitric oxide pathway, endothelin receptors, prostaglandin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5004a0883f846f954268e28f86b57bf0
https://doi.org/10.1016/j.ijpharm.2022.121792
https://doi.org/10.1016/j.ijpharm.2022.121792
Publikováno v:
International Journal of Pharmaceutics: X, Vol 2, Iss, Pp 100053-(2020)
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X
Vaccines delivered via the mucosal route have logistic benefits over parenteral or intramuscular vaccines as they offer patient compliance. This study presents the first intranasal, controlled release, subunit nanovaccine comprising mucoadhesive tama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8c127181a86ced89b67ffc7b08631a
https://pubmed.ncbi.nlm.nih.gov/32776000
https://pubmed.ncbi.nlm.nih.gov/32776000
Autor:
Sagar Dhoble, Vandana B. Patravale
Publikováno v:
Drug delivery and translational research. 9(5)
Pulmonary arterial hypertension (PAH) is the increase in mean pulmonary arterial pressure (> 25 mmHg). The development of the non-reversible plexiform lesions on the arterial walls of the pulmonary arteries has evolved as the reason to increase the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59fa24929c40decfd4cf29a5b6ad44f1
https://pubmed.ncbi.nlm.nih.gov/31001718
https://pubmed.ncbi.nlm.nih.gov/31001718
Publikováno v:
Novel Drug Delivery Technologies ISBN: 9789811336416
The discovery of new therapeutic agents and targets depending upon the pathophysiology of various diseases has necessitated the delivery of therapeutic molecules to specific cellular sub-compartments. The efficiency of various treatments can be impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66567ed0045d2dde3c0de15bcd01efe1
https://doi.org/10.1007/978-981-13-3642-3_12
https://doi.org/10.1007/978-981-13-3642-3_12
Publikováno v:
Journal of Drug Delivery Science and Technology. 62:102396
Pulmonary Hypertension (PH) is the progressive increase in mean pulmonary arterial pressure (≥ 20 mmHg at rest). Current treatment modalities involve the drugs targeting at nitric oxide pathway, prostaglandin receptors, thromboxane receptors, endot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b3fe3bc0557aa08025950d14466b7fa
https://doi.org/10.1016/j.jddst.2021.102396
https://doi.org/10.1016/j.jddst.2021.102396